AccuFFRangio Plus
X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device. 510(k) K230303, from ArteryFlow Technology Co., Ltd. (Hangzhou City, CN). Product code QHA, class 2.
As of Nov 21, 2026, K230303 is an FDA 510(k) held by ArteryFlow Technology Co., Ltd., substantially equivalent on Mar 2, 2023 after 27 days, with no recalls tied to it in FDA's recall database.
- Review time: 27 days
- Recalls: 0
AccuFFRangio Plus is indicated for use in clinical settings where validated and repreproducible quantified results are needed to support the assessment of coronary vessels in X-ray angiographic images, for use on individual patients with coronary artery disease.
- AccuFFRangioK210093 · ArteryFlow Technology Co., Ltd. · Sep 10, 2021
- X1-FFRK251355 · Spectrawave, Inc. · Oct 17, 2025
- Qfr (3.0)K243769 · Qfr Solutions BV · Apr 4, 2025
- CAAS WorkstationK232147 · Pie Medical Imaging BV · Apr 9, 2024
- AccuICASK221711 · ArteryFlow Technology Co., Ltd. · Feb 28, 2023
- AccuFFRangioK210093 · ArteryFlow Technology Co., Ltd. · Sep 10, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Feb 3, 2023
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1600
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files